Clinical Trial Update: Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Galvus (vildagliptin) in elderly adults with Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED